The ratio of blood platelet monoamineoxidase to aldehyde reductase activity in paranoid schizophrenia
Landowski, J.; Wontrobski, Z.
Psychiatria Polska 15(2): 133-137
1981
ISSN/ISBN: 0033-2674 PMID: 7312994 Document Number: 178325
Document emailed within 1 workday
Related Documents
Kuleshova, D.K.; Davydov, V.V.; Shvets, V.N. 2012: Aldehyde reductase activity and blood aldo-keto reductase spectrum in adolescents with neuroendocrine obesity Ukrains'kyi Biokhimichnyi Zhurnal 84(6): 96-100Landowski, J. 1977: Blood platelet MAO activity in various forms of schizophrenia Psychiatria Polska 11(5): 505-510
Ansari, N.H.; Bhatnagar, A.; Liu, S.Q.; Srivastava, S.K. 1991: Purification and characterization of aldose reductase and aldehyde reductase from human kidney Biochemistry International 25(4): 755-765
Fomina, E.V.; Davydov, V.V. 2004: Peculiarities of pH influence on aldehyde reductase activity in the liver of rats from different age groups subject to immobilization stress Ukrains'kyi Biokhimichnyi Zhurnal 76(6): 83-87
Zaytseva, Y.; Burova, V.; Garakh, Z.; Gurovich, I.Y. 2013: Attributional style in fist episode of schizophrenia and schizophrenia spectrum disorders with and without paranoid ideation Psychiatria Danubina 25(Suppl 2): S329-S331
Pozniakova, T.N.; Konoplitskaia, K.L.; Zakashun, T.E.; Khustochka, L.N. 1987: Disulfiram inhibition of aldehyde reductase from the rat liver Ukrainskii Biokhimicheskii Zhurnal 59(3): 19-23
Nakayama, T.; Tanimoto, T.; Kador, P.F. 1989: Human erythrocyte aldose and aldehyde reductase Progress in Clinical and Biological Research 290: 265-277
Bareggi, S.R.; Carminati, P.; Manara, L. 1971: Metaraminol and monoamineoxidase activity in the rat heart Research Communications in Chemical Pathology and Pharmacology 2(3): 347-354
Wyatt, R.J.; Potkin, S.G.; Murphy, D.L. 1979: Platelet monoamine oxidase activity in schizophrenia: a review of the data American Journal of Psychiatry 136(4a): 377-385
Apter, A.; Spivak, B.; Weizman, A.; Tyano, S.; Orvaschel, H. 1991: Paranoid schizophrenia in adolescence Journal of Clinical Psychiatry 52(9): 365-368
Abrahamson, D. 1997: On an engaging patient with paranoid schizophrenia American Journal of Psychiatry 154(8): 1178
Bokov, S.N. 1988: Affectivity of patients with paranoid schizophrenia Vrachebnoe Delo 4: 108-109
Walker, E. 1974: Nursing care study: paranoid schizophrenia Nursing Mirror and Midwives Journal 138(6): 86-87
Pic'l, A.K.; Magaro, P.A.; Wade, E.A. 1979: Hemispheric functioning in paranoid and nonparanoid schizophrenia Biological Psychiatry 14(6): 891-903
Vinokur, D. 1975: Genetic differentiation between paranoid and hebephrenic schizophrenia Vestnik Akademii Meditsinskikh Nauk SSSR 9: 32-36
Sukhovskiĭ, A.A. 1977: Clinical picture and course of paranoid schizophrenia in advanced age Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 77(9): 1377-1382
Golik, A.N. 1995: Variants in the dynamics of paranoid drive in schizophrenia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 95(5): 57-61
Liput, M.; Kajdaniuk, D.; Rokicka, D.; Marek, B. 2019: Hypercalcaemia in a patient with paranoid schizophrenia - a case report Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 47(279): 103-105
Kaflik, R.; Madrzak, M. 1979: Case of child schizophrenia with unusual paranoid symptoms Psychiatria Polska 13(5): 523-526
Hayes, J.D.; McLeod, R.; Ellis, E.M.; Pulford, D.J.; Ireland, L.S.; McLellan, L.I.; Judah, D.J.; Manson, M.M.; Neal, G.E. 1996: Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1 Iarc Scientific Publications 139: 175-187